Epstein Secrets

<https://www.washingtontimes.corn/news/2020/nov/15/biden-adviser-ron-klain-trump-stonewalling-harming/> EFTA00137221 (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key officia

n made after the election as the Biden team continues to wait for access government officials and resources to begin the formal transition process." Klain said, "There's a lot of things that are going to have to wait until Joe Biden is president, but this is not one of them.... This is a national cris

Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and CEO Liz Schrayer; 12:00 PM * Bicameral Dems discuss pas

g it a `giant logistical project;" and he "said the GSA's stonewalling is making that difficult." The AP (11/15, Alonso-Zaldivar, Weissert) reports Klain "said Biden's experts also need a detailed understanding of distribution plans being finalized by the Department of Health and Human Services and t

dlined "Biden Turns Up Pressure for Administration Recognition" provides similar coverage, as does the Washington Times (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key offici

Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and CEO Liz Schrayer; 12:00 PM • Bicameral Dems discuss pa

g it a `giant logistical project;" and he "said the GSA's stonewalling is making that difficult." The AP (11/15, Alonso-Zaldivar, Weissert) reports Klain "said Biden's experts also need a detailed understanding of distribution plans being finalized by the Department of Health and Human Services and t

dlined "Biden Turns Up Pressure for Administration Recognition" provides similar coverage, as does the Washington Times (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key offici

Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and CEO Liz Schrayer; 12:00 PM • Bicameral Dems discuss pa

g it a `giant logistical project;" and he "said the GSA's stonewalling is making that difficult." The AP (11/15, Alonso-Zaldivar, Weissert) reports Klain "said Biden's experts also need a detailed understanding of distribution plans being finalized by the Department of Health and Human Services and t

dlined "Biden Turns Up Pressure for Administration Recognition" provides similar coverage, as does the Washington Times (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key offici

Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and CEO Liz Schrayer; 12:00 PM • Bicameral Dems discuss pa